These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 11004699

  • 1. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates.
    Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ.
    J Pathol; 2000 Oct; 192(2):221-8. PubMed ID: 11004699
    [Abstract] [Full Text] [Related]

  • 2. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
    Rajan S, Zaidi G, Agarwal G, Mishra A, Agarwal A, Mishra SK, Bhatia E.
    World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
    [Abstract] [Full Text] [Related]

  • 3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S, Havelka M, Paunović I, Bozić V, Diklic A, Brasanac D, Janković R, Jancić-Zguricas M.
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [Abstract] [Full Text] [Related]

  • 4. Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome.
    Korpershoek E, Petri BJ, Post E, van Eijck CH, Oldenburg RA, Belt EJ, de Herder WW, de Krijger RR, Dinjens WN.
    Neoplasia; 2014 Oct; 16(10):868-73. PubMed ID: 25379023
    [Abstract] [Full Text] [Related]

  • 5. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
    Kousseff BG.
    Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
    [Abstract] [Full Text] [Related]

  • 6. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
    Stenman A, Zedenius J, Juhlin CC.
    Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
    [Abstract] [Full Text] [Related]

  • 7. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P, Roth J, Schröder S, Saremaslani P, Heitz PU.
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [Abstract] [Full Text] [Related]

  • 8. [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study].
    Gosset P, Lecomte-Houcke M, Duhamel A, Labat-Moleur F, Patey M, Floquet J, Viennet G, Berger-Dutrieux N, Caillou B, Franc B.
    Ann Pathol; 1999 Dec; 19(6):480-6. PubMed ID: 10617804
    [Abstract] [Full Text] [Related]

  • 9. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.
    Díaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ.
    Am J Pathol; 2000 Jan; 156(1):311-9. PubMed ID: 10623680
    [Abstract] [Full Text] [Related]

  • 10. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair.
    Blanes A, Sanchez-Carrillo JJ, Diaz-Cano SJ.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1150-8. PubMed ID: 16394087
    [Abstract] [Full Text] [Related]

  • 11. Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2.
    Nelkin BD, Ball DW, Baylin SB.
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):187-213. PubMed ID: 7913025
    [Abstract] [Full Text] [Related]

  • 12. Clonal analysis of sporadic pancreatic endocrine tumours.
    Perren A, Roth J, Muletta-Feurer S, Saremaslani P, Speel EJ, Heitz PU, Komminoth P.
    J Pathol; 1998 Dec; 186(4):363-71. PubMed ID: 10209484
    [Abstract] [Full Text] [Related]

  • 13. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
    Dammann R, Schagdarsurengin U, Seidel C, Trümpler C, Hoang-Vu C, Gimm O, Dralle H, Pfeifer GP, Brauckhoff M.
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
    [Abstract] [Full Text] [Related]

  • 14. Adrenomedullary hyperplasia and phaeochromocytoma. DNA cytophotometric findings in 47 cases.
    Padberg BC, Garbe E, Achilles E, Dralle H, Bressel M, Schröder S.
    Virchows Arch A Pathol Anat Histopathol; 1990 Jan; 416(5):443-6. PubMed ID: 2107632
    [Abstract] [Full Text] [Related]

  • 15. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [Abstract] [Full Text] [Related]

  • 16. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
    Diaz-Cano SJ, de Miguel M, Blanes A, Galera H, Wolfe HJ.
    Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
    [Abstract] [Full Text] [Related]

  • 17. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
    Korpershoek E, Stobbe CK, van Nederveen FH, de Krijger RR, Dinjens WN.
    Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782
    [Abstract] [Full Text] [Related]

  • 18. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ, Krohn-Grimberghe B, Görtz B, Litzlbauer D, Stracke H, Raue F, Kaiser HE.
    Anticancer Res; 2000 Sep; 20(6C):4877-87. PubMed ID: 11205236
    [Abstract] [Full Text] [Related]

  • 19. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
    Machens A, Dralle H.
    Mol Cell Endocrinol; 2006 Mar 09; 247(1-2):34-40. PubMed ID: 16343738
    [Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 09; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.